Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a Phase 1 clinical trial titled ‘A PHASE 1, ...

Integrative approaches targeting neurological and immune pathways may help break the itch–scratch cycle in atopic dermatitis, improving pruritus, stress, sleep, and patient outcomes.

Individuals presenting with one of several immune-mediated skin diseases may also have a substantially higher risk for keratoconus (KC), according to a large multicenter investigation published in ...

August 13, 2025STRATA Skin Sciences, Inc. misses on earnings expectations. Reported EPS is $-0.6 EPS, expectations were $-0.24. Operator: Ladies and gentlemen, thank you for standing by. Good ...

Dupixent shows potential as a treatment for atopic dermatitis, alopecia and vitiligo, targeting shared immune pathways for ...

Recent research confirms that aluminum in childhood vaccines does not increase the risk of autoimmune, allergic or ...

For patients with skin of color and atopic dermatitis (AD), lebrikizumab is efficacious and safe, according to a study ...

Any vitamin D treatment in pregnancy may help prevent childhood asthma (1 study, 236 participants), and higher-dose vitamin D treatment in pregnancy likely helps prevent childhood wheeze (3 studies, ...

Patients with moderate to severe and severe alopecia areata have a greater burden of comorbid atopic dermatitis than those with mild alopecia areata.

Dupilumab use for atopic dermatitis and other conditions was associated with an increased risk of incident psoriasis but not psoriatic arthritis.

Apogee plans to conduct Phase 2b trials in asthma and eosinophilic esophagitis (EoE) with trial designs informed by APEX Part B dose optimization as well as the Phase 1b results in asthma. Apogee ...

Phase 1 healthy volunteer data surpassing Kymera’s target product profile, and further validating its oral, dupilumab-like profile KT-621 BroADen Phase 1b trial in moderate to severe atopic dermatitis ...